Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021
Report Summary :
The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report segments the needle-free injection system market based on product, technology, usability, type, site of delivery, applications, end user and regions.
Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares
Table of Contents
The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report segments the needle-free injection system market based on product, technology, usability, type, site of delivery, applications, end user and regions.
Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares
Table of Contents
1 INTRODUCTION 16
2 RESEARCH METHODOLOGY 20
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 33
5 MARKET OVERVIEW 38
6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT 47
7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY 51
8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE 57
9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY 61
10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY
65
11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION 70
12 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER 77
13 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION 84
14 COMPETITIVE LANDSCAPE 154
15 COMPANY PROFILES 159
16 APPENDIX 173
Comments
Post a Comment